Identity & origin
BOTANICAL IDENTITY
The right name is the first step.
Kew describes this taxon as a subshrub. This notice concerns Lavandula stoechas, family Lamiaceae. The pharmacopoeial material is: flowers, flowering tops.
Results are presented to explain the research; no self-medication recommendation.
Also known as: Lavande stoechas, Lavandula stoechas
Lavandula stoechas differs from true lavender, Lavandula angustifolia. Studies and products labelled simply “lavender” do not all apply to this species.A photograph alone does not guarantee identification for consumption.
An illustration is not enough to identify a plant for consumption. Do not forage for a species based solely on this profile.
Uses & evidence
UNDERSTANDING THE USES
Properties & uses.
Inflammation: cultured macrophages
The investigated action concerns laboratory immune cells. It establishes neither an inflammation treatment nor a human smoking-cessation aid.
Laboratory or animal observation. A human benefit cannot be inferred from this finding alone.
Read the sourceThe traditional uses described are not clinical proof of effectiveness. Evidence for one preparation cannot automatically be applied to another.
Precautions before use
BEFORE ANY USE
Precautions & contraindications.
This guidance does not cover every individual situation. Missing information is not a guarantee of safety.
Contraindications & precautions
- Insufficient dataThis targeted audit does not provide a comprehensive contraindication review; this does not mean contraindications are absent.
Medicine interactions
- Insufficient dataThis dossier cannot establish compatibility with medication. A limited study does not replace an interaction review of the exact product.
Other retained warnings · review incomplete
These existing warnings remain relevant to consult. Their exhaustive reassessment is outside this targeted review.
Restrictions and precautions
- The references in this notice do not establish a complete contraindication list. This limitation does not mean absence of risk.
Medicine interactions
- Medicine compatibility is not assessed in this notice; a pharmacist should check it before any use.
Pregnancy, breastfeeding and children
The retained data do not support recommending medicinal use during pregnancy or breastfeeding.
No paediatric use is proposed; pharmacopoeial listing does not establish a child-appropriate dose.
“Reported” does not prove causality; “possible” may reflect indirect evidence. “None reported” means none in the cited source, not that all combinations have been studied. Do not stop a prescribed treatment based on this profile.
Adverse effects
- The inventory alone does not establish adverse-effect type or frequency.
Pregnancy & breastfeeding
The retained data do not support recommending medicinal use during pregnancy or breastfeeding.
Children & adolescents
No paediatric use is proposed; pharmacopoeial listing does not establish a child-appropriate dose.
If symptoms persist, worsen or are unusual, consult a healthcare professional. In an emergency, contact the emergency services.
Available evidence
EXPLORE THE EVIDENCE
The available evidence.
The investigated action concerns laboratory immune cells. It establishes neither an inflammation treatment nor a human smoking-cessation aid.
Inflammation: cultured macrophages
Extract and oil reduced reactive oxygen species, TNF-α and IL-6 after inflammatory stimulation.
Laboratory or animal observation. A human benefit cannot be inferred from this finding alone.
Read the referenceLimitations to keep in mind.
Do not ingest the essential oil or substitute it for smoking-cessation treatment.
Studies, findings & limitations
THE RESEARCH
What the research shows.
A laboratory or animal result alone does not demonstrate a benefit in humans. Each result must be read alongside the preparation studied and its limitations.
Inflammation: cultured macrophages
Laboratory or animal observation. A human benefit cannot be inferred from this finding alone.
- Type of research
- THP-1 macrophage culture and molecular modelling.
- Preparation concerned
- Lavandula stoechas extract and essential oil.
- Observed results
- Modelling suggests a possible nicotinic-receptor interaction, not clinical confirmation.
- Limitations to consider
- Cell concentrations and binding simulations cannot establish effectiveness or safety in a person.
What can we take from this?
Cell concentrations and binding simulations cannot establish effectiveness or safety in a person.
Documentary review dated 09/10/2026. The references remain available to check the context.
Sources & last review
CHECKING REFERENCES
Sources for this profile.
- ANSM — French Pharmacopoeia, List A, January 2026, p. 21Accessed on 09/10/2026
- GBIF — taxonomy of Lavandula stoechasAccessed on 09/10/2026
- Kew POWO — Lavandula stoechas L.Accessed on 09/10/2026
- Anti-inflammatory and antioxidant effects of Lavandula stoechas L. on human macrophages and in silico prediction of α7 nicotinic acetylcholine receptor interaction. — Baris E et al. (2026)Accessed on 09/10/2026
Image: Michael D. Pirie · CC BY 4.0. View the original image and its licence. Image resized and converted to WebP.